Stone Toro Investment Advisers’s AstraZeneca AZN Stock Holding History

Stone Toro Investment Advisers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$212K	Buy	+3,100	New	+$215K	2.13%	21

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Stone Toro Investment Advisers's AZN Position: Q1 2015 in Review

Stone Toro Investment Advisers opened a new position in AstraZeneca (AZN) in Q1 2015: 3,100 shares worth $212K. The stake represents 2.13% of the portfolio and ranks #21 among its holdings.

386 funds tracked by Wall St. Rank hold AZN as of Q1 2015.

Stone Toro Investment Advisers held 3,100 shares of AstraZeneca worth $212K as of Q1 2015.
AstraZeneca was a new Stone Toro Investment Advisers position in Q1 2015.
AstraZeneca made up 2.13% of Stone Toro Investment Advisers's portfolio in Q1 2015, its #21 holding.
386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2015.

Based on Stone Toro Investment Advisers's 13F filing for Q1 2015, filed 7 May 2015.